au.\*:("LAMENDOLA, Cindy")
Results 1 to 25 of 35
Selection :
What is the effect of rosiglitazone treatment on insulin secretory function in insulin-resistant individuals? It depends on how you measure itABBASI, Fahim; LAMENDOLA, Cindy; REAVEN, Gerald M et al.Metabolism, clinical and experimental. 2011, Vol 60, Num 1, pp 57-62, issn 0026-0495, 6 p.Article
Heterogeneity in the prevalence of risk factors for cardiovascular disease and type 2 diabetes mellitus in obese individuals : Effect of differences in insulin sensitivityMCLAUGHLIN, Tracey; ABBASI, Fahim; LAMENDOLA, Cindy et al.Archives of internal medicine (1960). 2007, Vol 167, Num 7, pp 642-648, issn 0003-9926, 7 p.Article
Effect of moderate alcoholic beverage consumption on insulin sensitivity in insulin-resistant, nondiabetic individualsKIM, Sun H; ABBASI, Fahim; LAMENDOLA, Cindy et al.Metabolism, clinical and experimental. 2009, Vol 58, Num 3, pp 387-392, issn 0026-0495, 6 p.Article
Prevalence of insulin resistance and associated cardiovascular disease risk factors among normal weight, overweight, and obese individualsMCLAUGHLIN, Tracey; ALLISON, Gregory; ABBASI, Fahim et al.Metabolism, clinical and experimental. 2004, Vol 53, Num 4, pp 495-499, issn 0026-0495, 5 p.Article
Use of a two-stage insulin infusion study to assess the relationship between insulin suppression of lipolysis and insulin-mediated glucose uptake in overweight/obese, nondiabetic womenMCLAUGHLIN, Tracey; YEE, Gail; GLASSFORD, Alec et al.Metabolism, clinical and experimental. 2011, Vol 60, Num 12, pp 1741-1747, issn 0026-0495, 7 p.Article
Serum alanine aminotransferase levels decrease further with carbohydrate than fat restriction in insulin-resistant adultsCELESTE RYAN, Marno; ABBASI, Fahim; LAMENDOLA, Cindy et al.Diabetes care. 2007, Vol 30, Num 5, pp 1075-1080, issn 0149-5992, 6 p.Article
Plasma ghrelin concentrations are decreased in insulin-resistant obese adults relative to equally obese insulin-sensitive controlsMCLAUGHLIN, Tracey; ABBASI, Fahim; LAMENDOLA, Cindy et al.The Journal of clinical endocrinology and metabolism. 2004, Vol 89, Num 4, pp 1630-1635, issn 0021-972X, 6 p.Article
Differentiation between obesity and insulin resistance in the association with C-reactive proteinMCLAUGHLIN, Tracey; ABBASI, Fahim; LAMENDOLA, Cindy et al.Circulation (New York, N.Y.). 2002, Vol 106, Num 23, pp 2908-2912, issn 0009-7322, 5 p.Article
Comparison of Three Treatment Approaches to Decreasing Cardiovascular Disease Risk in Nondiabetic Insulin-Resistant Dyslipidemic SubjectsABBASI, Fahim; CHEN, Yii-Der Ida; FARIN, Helke M. F et al.The American journal of cardiology. 2008, Vol 102, Num 1, pp 64-69, issn 0002-9149, 6 p.Article
Use of metabolic markers To identify Overweight individuals who are Insulin resistantMCLAUGHLIN, Tracey; ABBASI, Fahim; CHEAL, Karen et al.Annals of internal medicine. 2003, Vol 139, Num 10, pp 802-809, issn 0003-4819, 8 p.Article
Clinical efficacy of two hypocaloric diets that vary in overweight patients with type 2 diabetes : Comparison of moderate fat versus carbohydrate reductionsMCLAUGHLIN, Tracey; CARTER, Susan; LAMENDOLA, Cindy et al.Diabetes care. 2007, Vol 30, Num 7, pp 1877-1879, issn 0149-5992, 3 p.Article
Prevalence of Insulin Resistance and Related Risk Factors for Cardiovascular Disease in Patients With Essential HypertensionLIMA, Nereida K. C; ABBASI, Fahim; LAMENDOLA, Cindy et al.American journal of hypertension. 2009, Vol 22, Num 1, pp 106-111, issn 0895-7061, 6 p.Article
Plasma adiponectin concentrations do not increase in association with moderate weight loss in insulin-resistant, obese womenABBASI, Fahim; LAMENDOLA, Cindy; MCLAUGHLIN, Tracey et al.Metabolism, clinical and experimental. 2004, Vol 53, Num 3, pp 280-283, issn 0026-0495, 4 p.Article
Usefulness of plasma glucose and insulin concentrations in identifying patients with insulin resistanceTUAN, Cheng-Yang; ABBASI, Fahim; LAMENDOLA, Cindy et al.The American journal of cardiology. 2003, Vol 92, Num 5, pp 606-610, issn 0002-9149, 5 p.Article
Comparison in patients with type 2 diabetes of fibric acid versus hepatic hydroxymethyl glutaryl-coenzyme A reductase inhibitor treatment of combined dyslipidemiaMCLAUGHLIN, Tracey; ABBASI, Fahim; LAMENDOLA, Cindy et al.Metabolism, clinical and experimental. 2002, Vol 51, Num 10, pp 1355-1359, issn 0026-0495Article
Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease?MCLAUGHLIN, Tracey; REAVEN, Gerald; ABBASI, Fahim et al.The American journal of cardiology. 2005, Vol 96, Num 3, pp 399-404, issn 0002-9149, 6 p.Article
Pioglitazone administration decreases cardiovascular disease risk factors in insulin-resistant smokersABBASI, Fahim; FARIN, Helke M. F; LAMENDOLA, Cindy et al.Metabolism, clinical and experimental. 2008, Vol 57, Num 8, pp 1108-1114, issn 0026-0495, 7 p.Article
Pancreatic beta cell function following liraglutide-augmented weight loss in individuals with prediabetes: analysis of a randomised, placebo-controlled studyKIM, Sun H; LIU, Alice; ARIEL, Danit et al.Diabetologia (Berlin). 2014, Vol 57, Num 3, pp 455-462, issn 0012-186X, 8 p.Article
Plasma asymmetric dimethylarginine concentrations are elevated in obese insulin-resistant women and fall with weight lossMCLAUGHLIN, Tracey; STÜHLINGER, Markus; LAMENDOLA, Cindy et al.The Journal of clinical endocrinology and metabolism. 2006, Vol 91, Num 5, pp 1896-1900, issn 0021-972X, 5 p.Article
Effect of metformin treatment on multiple cardiovascular disease risk factors in patients with type 2 diabetes mellitusABBASI, Fahim; CHU, James W; MCLAUGHLIN, Tracey et al.Metabolism, clinical and experimental. 2004, Vol 53, Num 2, pp 159-164, issn 0026-0495, 6 p.Article
Comparative effects of rosuvastatin and gemfibrozil on glucose, insulin, and lipid metabolism in insulin-resistant, nondiabetic patients with combined dyslipidemiaLAMENDOLA, Cindy; ABBASI, Fahim; CHU, James W et al.The American journal of cardiology. 2005, Vol 95, Num 2, pp 189-193, issn 0002-9149, 5 p.Article
Relationship to insulin resistance of the Adult Treatment Panel III diagnostic criteria for identification of the metabolic syndromeCHEAL, Karen L; ABBASI, Fahim; LAMENDOLA, Cindy et al.Diabetes (New York, NY). 2004, Vol 53, Num 5, pp 1195-1200, issn 0012-1797, 6 p.Article
Relationship between Insulin resistance and an endogenous nitric oxide synthase inhibitorSTÜHLINGER, Markus C; ABBASI, Fahim; CHU, James W et al.JAMA, the journal of the American Medical Association. 2002, Vol 287, Num 11, pp 1420-1426, issn 0098-7484Article
Relationship between obesity, Insulin resistance, and coronary heart disease riskABBASI, Fahim; BROWN, Byron William; LAMENDOLA, Cindy et al.Journal of the American College of Cardiology. 2002, Vol 40, Num 5, pp 937-945, issn 0735-1097Article
Benefits of Liraglutide Treatment in Overweight and Obese Older Individuals With PrediabetesKIM, Sun H; ABBASI, Fahim; IDA, Yii-Der et al.Diabetes care. 2013, Vol 36, Num 10, pp 3276-3282, issn 0149-5992, 7 p.Article